Invention Grant
- Patent Title: Triazine based radiopharmaceuticals and radioimaging agents
-
Application No.: US17129825Application Date: 2020-12-21
-
Publication No.: US11712485B2Publication Date: 2023-08-01
- Inventor: John W. Babich , Craig Zimmerman , John L. Joyal , Genliang Lu
- Applicant: Molecular Insight Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Molecular Insight Pharmaceuticals, Inc.
- Current Assignee: Molecular Insight Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Foley & Lardner LLP
- The original application number of the division: US14152864 2014.01.10
- Main IPC: A61K51/04
- IPC: A61K51/04 ; C07D401/14 ; C07D403/14 ; C07D413/14 ; C07F5/00 ; A61B6/00
Abstract:
Metal complexes including a radionuclide and a compound of Formula I and Formula II are potent inhibitors of PSMA.
Public/Granted literature
- US20210338850A1 TRIAZINE BASED RADIOPHARMACEUTICALS AND RADIOIMAGING AGENTS Public/Granted day:2021-11-04
Information query
